Japan’s Fujifilm jumped into biologics contract manufacturing about 5 years ago by buying two plants from Merck & Co., when the U.S. drugmaker dropped that…

Merck KGaA wants to be a go-to company to help others develop and manufacture gene-related therapies and will expand its campus in Carlsbad, CA, by nearly 50%…

Despite a stumbling economy in recent years, Russia still holds a lot of appeal as an emerging market for drugmakers. Japan's Eisai is planning a major…

By year-end, the United Arab Emirates (UAE) can expect to have a new manufacturing plant producing drugs for the country as a Saudi drugmaker completes the…

Novartis put a Sandoz intermediates plant in Germany on the chopping block last year, saying that Asian competition had eviscerated the market for its products…

Recipharm has been continent-hopping to do a series of deals that expand both its geographic reach and its capabilities. Last fall, it struck a deal to buy an…

GlaxoSmithKline is upping its presence in India again, this week saying it'll spend INR500 million ($73 million) on a plant upgrade in Nashik to expand…

Regulators in Spain are punishing a Barcelona-based drugmaker for a series of manufacturing shortfalls, recalling all batches produced by the company, Farma…

Capsulemaker Qualicaps is adding another country, and another continent, to its manufacturing network. It has secured a spot in Brazil with the acquisition of…

Partnering